Current Medical Research and Opinion

The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension
pp. 327-332(6)
Authors: Giannelli, Gianluigi; Iannone, Florenzo; Marinosci, Felice; Lapadula, Giovanni; Antonaci, Salvatore

Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias
pp. 333-338(6)
Authors: Wierzbicki, Anthony S.; Doherty, Emma; Lumb, Peter J.; Chik, George; Crook, Martin A.

Do older patients feel able to cope with illness following telephone consultations? A multi-practice survey in the UK
pp. 339-344(6)
Authors: Jiwa, Moyez; Freeman, Jenny; Coleman, Martyn; Joesbury, Helen

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression
pp. 345-356(12)
Authors: Cowen, Philip J.; Ogilvie, Alan D.; Gama, Joubert

CARDS on the table: should everybody with type 2 diabetes take a statin?
pp. 357-362(6)
Authors: Lee, J.D.; Morrissey, J.R.; Mikhailidis, D.P.; Patel, V.

The effect of granisetron on in vitro metabolism of doxorubicin, irinotecan and etoposide
pp. 363-368(6)
Authors: Watanabe, Yoh; Nakai, Hidekatsu; Hoshiai, Hiroshi

Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteers
pp. 369-374(6)
Authors: Mundorf, Thomas K.; Ogawa, Takahiro; Inui, Noritsugu; Naka, Hiroaki; Novack, Gary D.; Crockett, R. Stephens

Clinical and economic issues associated with switching between triptans in clinical practice
pp. 375-380(6)
Authors: Dowson, A.J.; Fuat, A.; Gruffydd-Jones, K.

Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial
pp. 381-390(10)
Authors: Loder, Elizabeth; Freitag, Frederick G.; Adelman, James; Pearlmand, Starr; Abu-Shakra, Susan

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE
pp. 391-402(12)
Authors: Chesnut, Charles H.; Ettinger, Mark P.; Miller, Paul D.; Baylink, David J.; Emkey, Ronald; Harris, Steven T.; Wasnich, Richard D.; Watts, Nelson B.; Schimmer, Ralph C.; Recker, Robert R.

Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent
pp. 403-412(10)
Authors: Amadori, S.; Fenaux, P.; Ludwig, H.; O'Dwyer, M.; Sanz, M.

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians
pp. 413-424(12)
Authors: Lipton, R.B.; Cutrer, F.M.; Goadsby, P.J.; Ferrari, M.D.; Dodick, D.W.; McCrory, D.; Liberman, J.N.; Williams, P.

A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis
pp. 425-432(8)
Authors: Yee, Richard W.; Tepedino, Michael; Bernstein, Paula; Jensen, Harold; Schiffman, Rhett; Whitcup, Scott M.

Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm
pp. 433-438(6)
Author: Bihari, Katalin

Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes
pp. 439-446(8)
Author: Cohen, Marc

Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting
pp. 447-456(10)
Authors: Guest, Julian F.; Ruiz, Francis J.; Tang, Reiping; Wang, Jeng-Yi; Changchien, Chung R.; Wexner, Steven; Choti, Michael A.

A review of the metabolic effects of sibutramine
pp. 457-468(12)
Authors: Filippatos, T.D.; Kiortsis, D.N.; Liberopoulos, E.N.; Mikhailidis, D.P.; Elisaf, M.S.